MiNK Therapeutics, Inc. (NASDAQ: INKT) reported Q1 EPS of ($0.70), $0.64 worse than the analyst estimate of ($0.06).

For earnings history and earnings-related data on MiNK Therapeutics, Inc. (INKT) click here.